These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 7596980)

  • 21. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18.
    Chen Z; Kamath P; Zhang S; Weil MM; Shillitoe EJ
    Cancer Gene Ther; 1995 Dec; 2(4):263-71. PubMed ID: 8548580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribozymes. Their functions and strategies for their use.
    Gibson SA; Shillitoe EJ
    Mol Biotechnol; 1997 Apr; 7(2):125-37. PubMed ID: 9219227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of ribozyme activity with short oligonucleotides.
    Komatsu Y
    Biol Pharm Bull; 2004 Apr; 27(4):457-62. PubMed ID: 15056847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programming a highly structured ribozyme into complex allostery using RNA oligonucleotides.
    Rouleau SG; Jodoin R; Bisaillon M; Perreault JP
    ACS Chem Biol; 2012 Nov; 7(11):1802-6. PubMed ID: 22950875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate.
    Goodchild J; Kohli V
    Arch Biochem Biophys; 1991 Feb; 284(2):386-91. PubMed ID: 1989522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolutionary optimization of the catalytic properties of a DNA-cleaving ribozyme.
    Tsang J; Joyce GF
    Biochemistry; 1994 May; 33(19):5966-73. PubMed ID: 8180226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro selection procedures for identifying DNA and RNA aptamers targeted to nucleic acids and proteins.
    Dausse E; Cazenave C; Rayner B; Toulmé JJ
    Methods Mol Biol; 2005; 288():391-410. PubMed ID: 15333917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability.
    Hendry P; McCall MJ; Santiago FS; Jennings PA
    Nucleic Acids Res; 1992 Nov; 20(21):5737-41. PubMed ID: 1280808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicase-attached novel hybrid ribozymes.
    Kawasaki H; Warashina M; Kuwabara T; Taira K
    Methods Mol Biol; 2004; 252():237-43. PubMed ID: 15017053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro selection of nucleic acids for diagnostic applications.
    Hesselberth J; Robertson MP; Jhaveri S; Ellington AD
    J Biotechnol; 2000 Mar; 74(1):15-25. PubMed ID: 10943569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of bridged nucleic acid analogues for antigene technology.
    Obika S
    Chem Pharm Bull (Tokyo); 2004 Dec; 52(12):1399-404. PubMed ID: 15577233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA double cleavage by a hairpin-derived twin ribozyme.
    Schmidt C; Welz R; Müller S
    Nucleic Acids Res; 2000 Feb; 28(4):886-94. PubMed ID: 10648779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereospecificity of oligonucleotide interactions revisited: no evidence for heterochiral hybridization and ribozyme/DNAzyme activity.
    Hoehlig K; Bethge L; Klussmann S
    PLoS One; 2015; 10(2):e0115328. PubMed ID: 25679211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of ribozyme cleavage activity by oligonucleotides.
    Komatsu Y; Ohtsuka E
    Methods Mol Biol; 2004; 252():165-77. PubMed ID: 15017048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locked and unlocked nucleosides in functional nucleic acids.
    Doessing H; Vester B
    Molecules; 2011 May; 16(6):4511-26. PubMed ID: 21629180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2'-O-methylation.
    Goodchild J
    Nucleic Acids Res; 1992 Sep; 20(17):4607-12. PubMed ID: 1383929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hammerhead ribozymes that selectively cleave the NPY Y1, Y4, and Y5 receptor full-length RNA.
    Wieland HA; Hamilton BS; Krist B
    Antisense Nucleic Acid Drug Dev; 1998 Oct; 8(5):435-40. PubMed ID: 9826270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.